Ectopic expression of wild‐type TFCP2L1 or the T177E phospho‐mimic variant stimulated tumor sphere‐forming ability (Fig 6G and H) and clonogenic potential in a limiting dilution assay (Fig 6I) irrespective of the BC cell subtype. Here, TFCP2L1 is linked to breast cancer.